367 related articles for article (PubMed ID: 37014551)
1. Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner.
Whitehead CA; Fang H; Su H; Morokoff AP; Kaye AH; Hanssen E; Nowell CJ; Drummond KJ; Greening DW; Vella LJ; Mantamadiotis T; Stylli SS
Cell Oncol (Dordr); 2023 Aug; 46(4):909-931. PubMed ID: 37014551
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of invadopodia activity in glioma cells by sublethal doses of irradiation and temozolomide.
Mao L; Whitehead CA; Paradiso L; Kaye AH; Morokoff AP; Luwor RB; Stylli SS
J Neurosurg; 2018 Sep; 129(3):598-610. PubMed ID: 29148898
[TBL] [Abstract][Full Text] [Related]
3. Invadopodia associated Thrombospondin-1 contributes to a post-therapy pro-invasive response in glioblastoma cells.
Whitehead CA; Morokoff AP; Kaye AH; Drummond KJ; Mantamadiotis T; Stylli SS
Exp Cell Res; 2023 Oct; 431(1):113743. PubMed ID: 37591452
[TBL] [Abstract][Full Text] [Related]
4. Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells.
Jones D; Whitehead CA; Dinevska M; Widodo SS; Furst LM; Morokoff AP; Kaye AH; Drummond KJ; Mantamadiotis T; Stylli SS
Mol Cell Biochem; 2023 Jun; 478(6):1251-1267. PubMed ID: 36302993
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs.
Whitehead CA; Nguyen HPT; Morokoff AP; Luwor RB; Paradiso L; Kaye AH; Mantamadiotis T; Stylli SS
Transl Oncol; 2018 Dec; 11(6):1406-1418. PubMed ID: 30219696
[TBL] [Abstract][Full Text] [Related]
6. Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtyping.
Lane R; Simon T; Vintu M; Solkin B; Koch B; Stewart N; Benstead-Hume G; Pearl FMG; Critchley G; Stebbing J; Giamas G
Commun Biol; 2019; 2():315. PubMed ID: 31453379
[TBL] [Abstract][Full Text] [Related]
7. Functionalisation of extracellular vesicles with cyclic-RGDyC potentially for glioblastoma targeted intracellular drug delivery.
Geng T; Leung E; Chamley LW; Wu Z
Biomater Adv; 2023 Jun; 149():213388. PubMed ID: 37003022
[TBL] [Abstract][Full Text] [Related]
8. Eliminating the original cargos of glioblastoma cell-derived small extracellular vesicles for efficient drug delivery to glioblastoma with improved biosafety.
Guo Y; Hu G; Xia Y; Li H; Yuan J; Zhang J; Chen Y; Guo H; Yang Y; Wang Y; Deng Z
Bioact Mater; 2022 Oct; 16():204-217. PubMed ID: 35386327
[TBL] [Abstract][Full Text] [Related]
9. Lactadherin immunoblockade in small extracellular vesicles inhibits sEV-mediated increase of pro-metastatic capacities.
Durán-Jara E; Del Campo M; Gutiérrez V; Wichmann I; Trigo C; Ezquer M; Lobos-González L
Biol Res; 2024 Jan; 57(1):1. PubMed ID: 38173019
[TBL] [Abstract][Full Text] [Related]
10. The interactome and spatial redistribution feature of Ca
Li T; Yi L; Hai L; Ma H; Tao Z; Zhang C; Abeysekera IR; Zhao K; Yang Y; Wang W; Liu B; Yu S; Tong L; Liu P; Zhu M; Ren B; Lin Y; Zhang K; Cheng C; Huang Y; Yang X
Cell Death Dis; 2018 Feb; 9(3):292. PubMed ID: 29463791
[TBL] [Abstract][Full Text] [Related]
11. Molecular Characterization of Temozolomide-Treated and Non Temozolomide-Treated Glioblastoma Cells Released Extracellular Vesicles and Their Role in the Macrophage Response.
Panzarini E; Tacconi S; Carata E; Mariano S; Tata AM; Dini L
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171763
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Radiation and Temozolomide-Induced Glioblastoma Invadopodia Activity Using Ion Channel Drugs.
Dinevska M; Gazibegovic N; Morokoff AP; Kaye AH; Drummond KJ; Mantamadiotis T; Stylli SS
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050088
[TBL] [Abstract][Full Text] [Related]
13. Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme.
Kosgodage US; Uysal-Onganer P; MacLatchy A; Kraev I; Chatterton NP; Nicholas AP; Inal JM; Lange S
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597867
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
[TBL] [Abstract][Full Text] [Related]
15. Membrane proteome analysis of glioblastoma cell invasion.
Mallawaaratchy DM; Buckland ME; McDonald KL; Li CC; Ly L; Sykes EK; Christopherson RI; Kaufman KL
J Neuropathol Exp Neurol; 2015 May; 74(5):425-41. PubMed ID: 25853691
[TBL] [Abstract][Full Text] [Related]
16. LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells.
Wu P; Guo Y; Xiao L; Yuan J; Tang C; Dong J; Qian Z
Cancer Immunol Immunother; 2023 Jul; 72(7):2179-2193. PubMed ID: 36853330
[TBL] [Abstract][Full Text] [Related]
17. Proteomic, Metabolomic, and Fatty Acid Profiling of Small Extracellular Vesicles from Glioblastoma Stem-Like Cells and Their Role in Tumor Heterogeneity.
Lokumcu T; Iskar M; Schneider M; Helm D; Klinke G; Schlicker L; Bethke F; Müller G; Richter K; Poschet G; Phillips E; Goidts V
ACS Nano; 2024 Jan; 18(3):2500-2519. PubMed ID: 38207106
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2.
Chen L; Li Z; Hu S; Deng Q; Hao P; Guo S
Cancer Chemother Pharmacol; 2022 Feb; 89(2):217-229. PubMed ID: 35039898
[TBL] [Abstract][Full Text] [Related]
19. Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles.
Zottel A; Šamec N; Kump A; Raspor Dall'Olio LR; Pužar Dominkuš P; Romih R; Hudoklin S; Mlakar J; Nikitin D; Sorokin M; Buzdin A; Jovčevska I; Komel R
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187334
[TBL] [Abstract][Full Text] [Related]
20. Small extracellular vesicles containing miR-486-5p promote angiogenesis after myocardial infarction in mice and nonhuman primates.
Li Q; Xu Y; Lv K; Wang Y; Zhong Z; Xiao C; Zhu K; Ni C; Wang K; Kong M; Li X; Fan Y; Zhang F; Chen Q; Li Y; Li Q; Liu C; Zhu J; Zhong S; Wang J; Chen Y; Zhao J; Zhu D; Wu R; Chen J; Zhu W; Yu H; Ardehali R; Zhang JJ; Wang J; Hu X
Sci Transl Med; 2021 Mar; 13(584):. PubMed ID: 33692129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
